SolasCure publishes phase IIa clinical trial report in leading wound care journal Post author: Post published:March 4, 2024 Post category:uncategorized Study demonstrates proof-of-concept and strong safety profile of Aurase Wound Gel in patients suffering from chronic wounds. You Might Also Like Study reveals how specific aging cells help repair injured tendons July 3, 2026 Study reveals gender differences in Rett syndrome progression October 17, 2024 Chilling discovery: Study reveals evolution of human cold and menthol sensing protein June 21, 2024